一名BRCA1和BRCA2基因均存在种系突变的乳腺癌/卵巢癌患者。 - Suppr

Suppr

超能文献

A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2.

作者信息

Ramus S J, Friedman L S, Gayther S A, Ponder B A, Bobrow L, van der Looji M, Papp J, Olah E

出版信息

Nat Genet. 1997 Jan;15(1):14-5. doi: 10.1038/ng0197-14.

DOI:10.1038/ng0197-14

PMID:8988162

Abstract

摘要

相似文献

A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2.

Nat Genet. 1997 Jan;15(1):14-5. doi: 10.1038/ng0197-14.

Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. Online.

Hum Mutat. 1998;12(3):215.

Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland.

Hum Mutat. 2000 May;15(5):480-1. doi: 10.1002/(SICI)1098-1004(200005)15:5<480::AID-HUMU13>3.0.CO;2-G.

Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations.

Hum Mutat. 2000 Jul;16(1):88-9. doi: 10.1002/1098-1004(200007)16:1<88::AID-HUMU16>3.0.CO;2-G.

A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.

Cas Lek Cesk. 2000 Oct 11;139(20):635-7.

High frequency of BRCA1 and BRCA2 germline mutations in Ashkenazi Jewish ovarian cancer patients, regardless of family history.

Gynecol Oncol. 1997 Nov;67(2):123-6. doi: 10.1006/gyno.1997.4844.

Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.

Breast Cancer Res Treat. 2006 Nov;100(1):83-91. doi: 10.1007/s10549-006-9225-9. Epub 2006 May 9.

Germline mutations of BRCA1 and BRCA2 in Korean breast and/or ovarian cancer families.

Hum Mutat. 2002 Sep;20(3):235. doi: 10.1002/humu.9059.

Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene.

Nat Genet. 1997 Jan;15(1):103-5. doi: 10.1038/ng0197-103.

BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients.

Eur J Hum Genet. 2001 Jun;9(6):424-30. doi: 10.1038/sj.ejhg.5200652.

引用本文的文献

Clinicopathological features of Chinese ovarian cancer patients with double heterozygosity for cancer-predisposed genes.

BMC Cancer. 2025 Aug 28;25(1):1391. doi: 10.1186/s12885-025-14835-0.

Case Report: Clinical impact of and vs. and germline double heterozygosity in ovarian cancer: a comparative case study.

Front Oncol. 2025 Jul 24;15:1614373. doi: 10.3389/fonc.2025.1614373. eCollection 2025.

Two-hit events occurred independently in bilateral breast cancers in a germline double heterozygous carrier for BRCA1 and BRCA2.

Breast Cancer. 2025 Jul 2. doi: 10.1007/s12282-025-01740-4.

Double heterozygosity for and in breast cancer: considerations in surveillance and cancer risk management.

BMJ Case Rep. 2025 Apr 22;18(4):e263687. doi: 10.1136/bcr-2024-263687.

Double Heterozygosity for Germline Mutations in Chinese Breast Cancer Patients.

Cancers (Basel). 2024 Jul 15;16(14):2547. doi: 10.3390/cancers16142547.

Metastatic breast cancer with double heterozygosity for the and genes responding to olaparib: A case report.

Oncol Lett. 2024 Apr 9;27(6):253. doi: 10.3892/ol.2024.14387. eCollection 2024 Jun.

Double Heterozygosity for Rare Deleterious Variants in the and Genes in a Hungarian Patient with Breast Cancer.

Int J Mol Sci. 2023 Oct 18;24(20):15334. doi: 10.3390/ijms242015334.

Variants Extend the Mutational Profile of Hungarian Patients with Breast and Ovarian Cancer.

Cancers (Basel). 2023 Aug 31;15(17):4350. doi: 10.3390/cancers15174350.

Clinicopathological Characterization of Double Heterozygosity for BRCA1 and BRCA2 Variants in Korean Breast Cancer Patients.

Cancer Res Treat. 2022 Jul;54(3):827-833. doi: 10.4143/crt.2021.791. Epub 2021 Oct 13.

Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination.

NPJ Breast Cancer. 2021 Oct 11;7(1):135. doi: 10.1038/s41523-021-00339-0.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验